Status:
COMPLETED
Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects
Lead Sponsor:
AstraZeneca
Conditions:
Alzheimer's Disease
Eligibility:
MALE
18-45 years
Phase:
PHASE1
Brief Summary
The purpose of the study is to evaluate if AZD3480 and warfarin interact with each other or not, i.e. show the same or altered plasma concentration profiles when co-administered compared to administer...
Eligibility Criteria
Inclusion
- Provision of signed written informed consent
- Clinically normal physical findings and laboratory values
Exclusion
- Clinically significant illness or clinically relevant trauma within three weeks before the first dose
- History of clinically significant disease
- Use of prescribed medication during the 2 weeks before administration of the first dose of investigational product
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2009
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00689559
Start Date
March 1 2008
End Date
April 1 2009
Last Update
July 2 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Uppsala, Sweden